IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

WeylChem Hunts for ‘Sizable’ Deals to Further Increase Sales

3:07 PM MST | February 18, 2008 | Alex Scott

Private equity-owned chemicals manufacturer WeylChem (Frankfurt) is seeking major acquisitions as part of a strategy to maintain strong double-digit sales growth, the company told CW at the Informex specialty and fine chemicals expo, held recently in New Orleans. WeylChem’s sales grew 70% in each of the past two years largely through acquisitions, to reach about €600 million ($873 million) in 2007. The company’s sales to the pharmaceuticals sector are about €250 million/year, making WeylChem a top-20 custom fine chemical player. Maintaining...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa